Erschienen in:
11.11.2023 | Letters of Biomedical and Clinical Research
Pitfalls in antiphospholipid antibody testing: specifically interference from anticoagulation
verfasst von:
Hammad Ali, Connor R. Buechler, Oneeb Sanaullah, Paramarajan Piranavan
Erschienen in:
Clinical Rheumatology
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
Antiphospholipid syndrome (APS) is an autoimmune phenomenon defined by macrovascular and microvascular thrombotic events, non-thrombotic manifestations, and pregnancy morbidity in the presence of persistent evidence of antiphospholipid antibodies (aPL) [
1]. aPL can be directed against phospholipids and/or phospholipid binding proteins, though only the latter have been shown to be pathogenic in APS [
1]. Because the protean manifestations of APS can be attributed to a variety of alternative etiologies, APS is a disease defined in the laboratory. However, laboratory testing for aPL comes with many pitfalls, particularly with regard to the increasing number of patients on anticoagulant medications. …